Idorsia Ltd (CHF)
IDIA
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range28.44 | 29.30
52-Wk Range15.20 | 30.88
Last Close28.56
Mkt Cap (m)3,748.07
Dividend yield-
ISINCH0363463438
Volume267,744
Exchange VenueSWX

Company Profile

Idorsia Ltd is a biopharmaceutical company specialized in the discovery, development and commercialization of molecule therapeutics to treat central nervous system, cardiovascular disorders, immunological disorders and orphan diseases.

Key Information
Price/Earning-
Price/Book11.45
Price/Sales61.79
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -612.15
Net Margin %-637.42
Return on Equity-54.80
Debt/Equity0.86

Legal Documents

Prospectus
en 26/06/2017
Annual Report
en 31/12/2018

Financials

Income Statement
CHF201320142015201620172018
Revenue (m)---15861
Operating Income (m)----323-8-371
Net Income (m)----335-14-386
Basic EPS----2.81-0.12-3.10
Avg. Diluted Shares Outstanding (m)---119119125
Balance Sheet
CHF201320142015201620172018
Current Assets (m)---753881941
Non Current Assets (m)---162411465
Total Assets (m)---9151,2921,407
Current Liabilities (m)---6693105
Total Liabilities (m)------
Total Equity (m)---512745665
Cash Flows
CHF201320142015201620172018
Operating Cash Flows (m)----26395-353
Capital Expenditure (m)----9-8-14
Figures are quoted in CHF unless stated otherwise
0.00 (0.00%)
28.56
Last Price